1999
DOI: 10.1177/120347549900300610
|View full text |Cite
|
Sign up to set email alerts
|

Interferon-Induced Cutaneous Necrosis

Abstract: Cutaneous inflammation or necrosis at interferon injection sites is not uncommon. Although interferon beta-1b is most commonly responsible for this complication, it is now increasingly reported with interferon alfa. It appears to be secondary to the proinflammatory effects of these cytokines or to their unmasking of a subtle hypercoagulable state.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4

Citation Types

0
7
0

Year Published

2002
2002
2016
2016

Publication Types

Select...
6
3

Relationship

0
9

Authors

Journals

citations
Cited by 15 publications
(7 citation statements)
references
References 19 publications
0
7
0
Order By: Relevance
“…On the contrary, a variety of reactions at injection sites of interferon alfa have been described including erythema, induration, 4 pyoderma gangrenosum, 5 interface dermatitis, 6 dermal hypersensitivity, 7 leukocytoclastic vasculitis, 8 necrotizing ulcerations 9,10 and suppurative and granulomatous dermatitis 11 . Other cutaneous reactions related to interferon beta‐1b include erythematous plaques, cutaneous ulcers or subtle uninflammed sclerotic dermal plaques at the injection sites 12 .…”
Section: Discussionmentioning
confidence: 99%
“…On the contrary, a variety of reactions at injection sites of interferon alfa have been described including erythema, induration, 4 pyoderma gangrenosum, 5 interface dermatitis, 6 dermal hypersensitivity, 7 leukocytoclastic vasculitis, 8 necrotizing ulcerations 9,10 and suppurative and granulomatous dermatitis 11 . Other cutaneous reactions related to interferon beta‐1b include erythematous plaques, cutaneous ulcers or subtle uninflammed sclerotic dermal plaques at the injection sites 12 .…”
Section: Discussionmentioning
confidence: 99%
“…1-3 Skin ulcerations seem to be an infrequent complication, usually not related to the dose or frequency of administration 4 : they have been reported to occur in less than 4% of patients treated with interferon beta, 5 and appear to occur even less frequently in association with interferon alfa. 6 In 1989 Rasokat et al 7 described the first two cases of aseptic necrosis of the skin after subcutaneous selfinjection of recombinant interferon alfa; the short delay (hours) after the injection and the clinical picture were consistent with inadvertent intraarterial embolization. Cutaneous necrosis caused by interferon alfa after several months of treatment was first reported by Cnudde et al 8 in 1991, and has been recently reviewed.…”
Section: Discussionmentioning
confidence: 96%
“…g) is a well-described adverse cutaneous drug reaction and can also exhibit signs of necrotizing vasculitis. [26][27][28][29][30] Thus, high local levels of IFN can in some instances cause massive localized tissue damage.…”
Section: Discussionmentioning
confidence: 99%